Key Takeaway
Comparing GHRP-6 vs GHRP-2 helps you understand the older generation of growth hormone secretagogues and why newer options like Ipamorelin have largely replaced them.
Comparing GHRP-6 vs GHRP-2 helps you understand the older generation of growth hormone secretagogues and why newer options like Ipamorelin have largely replaced them. Both stimulate GH release through the ghrelin receptor, but they differ significantly in selectivity, side effects, and appetite stimulation.
Key Takeaways: - Head-to-Head Comparison - When GHRP-6 or GHRP-2 Might Be Preferred - Dosing Protocols - Side Effect Comparison
If your provider has discussed these peptides with you, this guide explains how they compare.
Head-to-Head Comparison
GHRP-6: - Potent GH secretagogue with strong ghrelin receptor activation - Dramatic appetite increase (the strongest among GH secretagogues) - Increases cortisol and prolactin levels alongside GH - Higher GH release per dose compared to Ipamorelin - Less selective, meaning broader hormonal impact - Useful for people who need to eat more (underweight, recovery)
GHRP-2: - Moderate GH secretagogue, slightly more selective than GHRP-6 - Moderate appetite increase (between GHRP-6 and Ipamorelin) - Some cortisol and prolactin elevation, less than GHRP-6 - Potent GH release, comparable to GHRP-6 - Better side effect profile than GHRP-6 but less clean than Ipamorelin
Ipamorelin (for comparison): - Most selective GH secretagogue available - Minimal appetite increase - No significant cortisol or prolactin elevation - Slightly lower GH release per dose than GHRP-6 or GHRP-2 - Fewest side effects of any GH secretagogue
The trend in clinical practice has moved decisively toward Ipamorelin because its selectivity means fewer unwanted hormonal effects. However, GHRP-6 and GHRP-2 still have specific use cases.
Learn about for GH optimization.
When GHRP-6 or GHRP-2 Might Be Preferred
Despite Ipamorelin's advantages, there are scenarios where the older secretagogues have value.
Free Download: Protocol Planner Compare all GH secretagogues side by side with dosing, timing, and expected effects. Get yours free) we'll email it to you instantly. [Download Your Free Protocol Planner]
GHRP-6 may be preferred when: - You need appetite stimulation (cancer recovery, severe underweight, eating disorders in recovery) - Maximum GH release per dose is the priority - You are comfortable managing the broader hormonal effects - Your provider specifically recommends it for your clinical situation
GHRP-2 may be preferred when: - You want stronger GH stimulation than Ipamorelin but better selectivity than GHRP-6 - Moderate appetite stimulation is acceptable or desired - You have tried Ipamorelin and want a more potent alternative - Your provider prefers the GHRP-2 response profile for your goals
Neither is preferred when: - You are trying to lose weight (appetite stimulation counterproductive) - You want to minimize hormonal side effects - You are combining with GLP-1 medications - You are concerned about cortisol elevation
Your can help determine which secretagogue best fits your situation.
Dosing Protocols
GHRP-6 standard protocol: - Dose: 100-300mcg per injection - Frequency: 2-3 times daily on empty stomach - Often combined with a GHRH analog (CJC-1295 or Sermorelin) - Expect significant hunger within 20-30 minutes of injection
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for physician-supervised GLP-1 therapy.
Try the BMI Calculator →GHRP-2 standard protocol: - Dose: 100-300mcg per injection - Frequency: 2-3 times daily on empty stomach - Combined with a GHRH analog for combined effect - Moderate hunger increase expected
Both require: - Fasting for 2+ hours before injection - No food for 30-60 minutes after injection - Consistent daily timing for best results - Cycling: 3 months on, 1 month off
Use the for accurate peptide preparation.
Track your protocol in the including appetite and side effect notes.
Side Effect Comparison
About the side effect differences helps inform your decision.
Appetite: GHRP-6 causes intense hunger within minutes of injection. GHRP-2 causes moderate hunger. Ipamorelin causes minimal hunger. If you are on a GLP-1 medication for weight loss, GHRP-6's appetite stimulation directly counteracts your treatment goals.
Cortisol elevation: GHRP-6 > GHRP-2 > Ipamorelin. Elevated cortisol promotes abdominal fat storage and muscle breakdown. This is counterproductive for body composition goals. Ipamorelin's negligible cortisol impact is a major advantage.
Prolactin elevation: GHRP-6 > GHRP-2 > Ipamorelin. Elevated prolactin can cause water retention, mood changes, and in men, potential sexual health effects. Again, Ipamorelin avoids this issue.
Water retention: All GH secretagogues can cause mild water retention. GHRP-6 and GHRP-2 may cause slightly more due to broader hormonal effects.
Injection site reactions: Similar across all three peptides. Mild and temporary.
Read about for in-depth safety information.
Frequently Asked Questions
Why have most providers moved away from GHRP-6 and GHRP-2?
Ipamorelin provides GH stimulation with significantly fewer side effects. The appetite increase, cortisol elevation, and prolactin elevation from GHRP-6 and GHRP-2 are unnecessary for most patients. Ipamorelin achieves the therapeutic goal (GH optimization) with a cleaner profile.
Can I combine GHRP-6 or GHRP-2 with Ipamorelin?
This is not standard practice. Combining two GH secretagogues that work through the same receptor provides diminishing returns and increases side effects. Choose one secretagogue and combine it with a GHRH analog (like CJC-1295) for the best combined effect.
Is GHRP-6 or GHRP-2 more effective than Ipamorelin for GH release?
Per-dose GH release is slightly higher with GHRP-6 and GHRP-2. However, this does not translate to better clinical outcomes for most goals. The broader hormonal effects of GHRP-6/2 can counteract the benefits of higher GH release.
Can I switch from GHRP-6/2 to Ipamorelin?
Yes. You can switch directly without a washout period. Most patients notice fewer side effects (less hunger, less water retention) immediately upon switching, with comparable GH benefits once the new protocol stabilizes.
Ready to Take the Next Step?
Your health outcomes is personal, and you deserve a plan that fits. FormBlends connects you with licensed providers who can evaluate your needs and create a personalized protocol.
Sources & References
- Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab. 2006;91(12):4792-4797. Doi:10.1210/jc.2006-1702
This content is provided for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed healthcare provider with any questions about a medical condition or treatment plan.
Last updated: 2026-03-24